Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The meningococcus and mechanisms of pathogenicity.

× No keyword cloud information.

239 in total

1. Carboxylation of phosphoenolpyruvate by extracts of Neisseria gonorrhoeae.

Authors: D L Cox; C L Baugh
Journal: J Bacteriol Date: 1977-01 Impact factor: 3.490

2. Gamma-M deficiency predisposing to meningococcal septicaemia.

Authors: J R Hobbs; R D Milner; P J Watt
Journal: Br Med J Date: 1967-12-09

3. Production of a capsule of Neisseria gonorrhoeae.

Authors: W P Richardson; J C Sadoff
Journal: Infect Immun Date: 1977-02 Impact factor: 3.441

4. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.

Authors: P H Mäkelä; H Peltola; H Käyhty; H Jousimies; O Pettay; E Ruoslahti; A Sivonen; O V Renkonen
Journal: J Infect Dis Date: 1977-08 Impact factor: 5.226

5. Pneumonia caused by Neisseria meningitidis.

Authors: S A Jacobs; C W Norden
Journal: JAMA Date: 1974-01-07 Impact factor: 56.272

6. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.

Authors: H Peltola; H Mäkelä; H Käyhty; H Jousimies; E Herva; K Hällström; A Sivonen; O V Renkonen; O Pettay; V Karanko; P Ahvonen; S Sarna
Journal: N Engl J Med Date: 1977-09-29 Impact factor: 91.245

7. Increased virulence of Neisseria meningitidis after in vitro iron-limited growth at low pH.

Authors: D Brener; I W DeVoe; B E Holbein
Journal: Infect Immun Date: 1981-07 Impact factor: 3.441

8. Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.

Authors: G H Lowell; L F Smith; J M Griffiss; B L Brandt; R P MacDermott
Journal: J Clin Invest Date: 1980-08 Impact factor: 14.808

9. EXPERIMENTAL CEREBRO-SPINAL MENINGITIS IN MONKEYS.

Authors: S Flexner
Journal: J Exp Med Date: 1907-03-14 Impact factor: 14.307

10. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.

Authors: C E Frasch; J D Robbins
Journal: J Exp Med Date: 1978-03-01 Impact factor: 14.307

49 in total

1. Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis.

Authors: J P Woods; J G Cannon
Journal: Infect Immun Date: 1990-02 Impact factor: 3.441

2. Use of DNA fingerprinting in an epidemiologic study of outbreak-specific and non-specific strains of group C Neisseria meningitidis.

Authors: B Facinelli; F Biavasco; P E Varaldo
Journal: Eur J Epidemiol Date: 1990-03 Impact factor: 8.082

Review 3. Iron acquisition and the pathogenesis of meningococcal and gonococcal disease.

Authors: J P van Putten
Journal: Med Microbiol Immunol Date: 1990 Impact factor: 3.402

Review 4. Animal models for pathogenic Neisseria species.

Authors: R J Arko
Journal: Clin Microbiol Rev Date: 1989-04 Impact factor: 26.132

5. Genes associated with meningococcal capsule complex are also found in Neisseria gonorrhoeae.

Authors: H Petering; S Hammerschmidt; M Frosch; J P van Putten; C A Ison; B D Robertson
Journal: J Bacteriol Date: 1996-06 Impact factor: 3.490

6. Human immune response to iron-repressible outer membrane proteins of Neisseria meningitidis.

Authors: J R Black; D W Dyer; M K Thompson; P F Sparling
Journal: Infect Immun Date: 1986-12 Impact factor: 3.441

7. Survival of meningococci outside of the host: implications for acquisition.

Authors: C L Swain; D R Martin
Journal: Epidemiol Infect Date: 2006-07-03 Impact factor: 2.451

8. Discovery of a novel protein modification: alpha-glycerophosphate is a substituent of meningococcal pilin.

Authors: E Stimson; M Virji; S Barker; M Panico; I Blench; J Saunders; G Payne; E R Moxon; A Dell; H R Morris
Journal: Biochem J Date: 1996-05-15 Impact factor: 3.857

9. The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.

Authors: C M Kahler; L E Martin; G C Shih; M M Rahman; R W Carlson; D S Stephens
Journal: Infect Immun Date: 1998-12 Impact factor: 3.441

Review 10. Meningococcal carriage and disease--population biology and evolution.

Authors: Dominique A Caugant; Martin C J Maiden
Journal: Vaccine Date: 2009-05-21 Impact factor: 3.641